Magle Chemoswed Holding AB
STO:MAGLE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Magle Chemoswed Holding AB
Total Current Liabilities
Magle Chemoswed Holding AB
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Magle Chemoswed Holding AB
STO:MAGLE
|
Total Current Liabilities
kr159.4m
|
CAGR 3-Years
45%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
AddLife AB
STO:ALIF B
|
Total Current Liabilities
kr4B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
BICO Group AB
STO:BICO
|
Total Current Liabilities
kr1.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
|
Biotage AB
STO:BIOT
|
Total Current Liabilities
kr467m
|
CAGR 3-Years
16%
|
CAGR 5-Years
18%
|
CAGR 10-Years
16%
|
|
|
G
|
Genovis AB
STO:GENO
|
Total Current Liabilities
kr28.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
15%
|
CAGR 10-Years
13%
|
|
|
MedCap AB (publ)
STO:MCAP
|
Total Current Liabilities
kr494.3m
|
CAGR 3-Years
18%
|
CAGR 5-Years
14%
|
CAGR 10-Years
8%
|
|
Magle Chemoswed Holding AB
Glance View
Magle Chemoswed Holding AB engages in the provision of contract development and manufacturing services to the pharmaceutical and medical device industry. The company is headquartered in Malmo, Skane. The company went IPO on 2020-06-30. The firm's operations are mainly conducted through the subsidiaries Magle Chemoswed AB and Adroit Science AB. The business is focused on process development and manufacturing of Active Pharmaceutical Ingredients (API) as well as research, development and manufacturing of products in the areas of wound care and diagnostics with particular focus on products based on degradables starch microspheres. Magle Chemoswed also functions as a consultancy in material characterization and solid phase analysis with a main focus on pharmaceutical companies.
See Also
What is Magle Chemoswed Holding AB's Total Current Liabilities?
Total Current Liabilities
159.4m
SEK
Based on the financial report for Dec 31, 2025, Magle Chemoswed Holding AB's Total Current Liabilities amounts to 159.4m SEK.
What is Magle Chemoswed Holding AB's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
27%
Over the last year, the Total Current Liabilities growth was -63%. The average annual Total Current Liabilities growth rates for Magle Chemoswed Holding AB have been 45% over the past three years , 27% over the past five years .
